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Abstract
Background: The Streptococcus Milleri/Anginosus Group (SMG) colonize mucosal surfaces, especially the airways,
and are considered to be normal mucosal microbiota; however, they are a major cause of abscesses, pneumonia
and pleural empyema. The production of exoenzymes and virulence factors do not correlate with SMG
pathogenicity. Since SMG infections are associated with robust inflammatory responses, we hypothesized that host
immune responses might distinguish strains associated with asymptomatic carriage and those associated with
fulminant disease.
Methods: We measured IL1β, TNF, IL10, IL12, IL23, IL17, and IL4 production from human peripheral blood
mononuclear cells (PBMCs) stimulated with a panel of clinical isolates from the airways and infections and
measured the ability of these isolates to stimulate TLR2.
Results: Isolates were categorized based on the levels of cytokines they induced from PBMCs (high, intermediate,
low). Airway isolates predominantly induced low levels of cytokines and isolates from invasive disease induced
higher levels, although about 10% of the strains produced divergent cytokine responses between donors.
Interestingly, the donors were most divergent in their production of IL17, IL12 and IL23.
Conclusions: We propose that the ability to inhibit or avoid an inflammatory response is associated with carriage
in the airways and variability in responses between isolates and donors might contribute to susceptibility to
disease.
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Background
The Streptococcus Milleri/Anginosus Group (SMG), in-
cluding the three species Streptococcus anginosus, Strepto-
coccus constellatus, and Streptococcus intermedius, are
considered commensal bacteria since they asymptomati-
cally colonize the gastrointestinal, female urogenital, and
respiratory tracts of 15-30% of the healthy population
[1,2]. They are, however, also causative agents of pyogenic
infections, accounting for 28-40% of brain abscesses [3,4],
20-44% of liver abscesses [5-7], 20% of head and neck ab-
scesses [8], and 30-50% of pleural empyema [9,10], all of
which are often complicated by bacteremia [11]. In addition
to causing acute invasive infections, we have recently iden-
tified the SMG as a chronic respiratory pathogen in cystic
fibrosis (CF) patients [12]. It is unclear whether there are
separate disease-causing and commensal strains of the
SMG. This is complicated largely by the vast genetic and
phenotypic heterogeneity of the three species. Clinical iso-
lates of the SMG exhibit inter- and intra-species diversity in
phenotypic characteristics, including biochemical proper-
ties, Lancefield grouping (A, C, G, F, non-groupable),
hemolysis on sheep’s blood agar (α, β, γ), and production
of putative virulence factors including the hydrolytic en-
zymes hyaluronidase (HA), chondroitin sulfatase (CS),
DNase, and proteases. Previous studies have shown that
there is no association between the phenotype of an iso-
late and its ability to cause infection [13,14].
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Since studies of phenotypic characteristics have not
been informative in distinguishing invasive or commensal
isolates of the SMG, we reasoned that host immune re-
sponses might contribute to pathogenicity. The pathology
of bacterial infections can be mediated either by damage
to host tissues directly or by the host’s immune response.
If the inflammatory response is not appropriately cali-
brated, it can drive tissue damage or, in systemic infec-
tions, excess cytokine production, which can be fatal
[15,16]. SMG infections are characterized by robust
neutrophilia and local and systemic inflammation [17],
whereas carriage (approximately ≤1 × 105 CFU/mL in
the lungs) does not appear to be accompanied by a ro-
bust immune response [18,19].
Commensal bacteria might be less immunogenic than
pathogenic bacteria or might induce an anti-inflammatory
response that contributes to their selection as long-term
residents of mucosal surfaces. For example, in a study
comparing dendritic cell production of IL23, IL12p70 and
IL10 after exposure to airway isolates, it was found that
the pathogenic species Morexella catarrhalis and Hae-
mophilus influenzae induced high levels of cytokines,
non-pathogenic isolates of Veillonella spp. and Actino-
myces spp. induced low levels of cytokines and non-
pathogenic isolates of Prevotella spp. induced low levels
of the inflammatory cytokines IL23 and IL12p70 but
high levels of the anti-inflammatory cytokine IL10 [20].
Similarly, the commensal bacteria Staphylococcus aureus
provokes divergent cytokine responses from macrophages,
peripheral blood mononuclear cells (PBMCs), and den-
dritic cells that possibly account for the varying outcomes
of carriage or infection. Macrophages, the sentinel cells of
the nasopharynx where S. aureus is a common colonizing
organism, produce IL10 in response to the bacteria, which
is speculated to contribute to colonization. Dendritic cells,
which are found in the circulation and in the skin, produce
IL12 or IL23, which might contribute to the immunopa-
thology of a systemic S. aureus infection [21-23]. These
studies suggest that cytokine responses could be determi-
nants of commensalism or pathogenicity.
To determine if cytokine responses to the SMG distin-
guish commensal from pathogenic isolates, we measured
the production of IL1β, TNF, IL10, IL23, 12p70, IL17A,
and IL4 from human PBMCs in response to 35 clinical iso-
lates from either invasive infections (abscesses, bacteremia,
empyema) or the CF airway cultured during periods of
stability or exacerbation. Cytokine profiles differed across
the 35 isolates resulting in a spectrum of responses that
separated into high, intermediate, and low levels of cyto-
kine production. The high and intermediate response
groups were enriched for invasive isolates, which induced
significantly higher levels of IL1β, TNF, IL10, IL23, and
IL12p70 production than did airway isolates. The
spectrum of cytokine profiles illustrates the heterogeneity
of the SMG and indicates that cytokine responses might
contribute to the potential of an isolate to colonize the air-
ways or cause infection.
Methods
Bacterial strains
The 35 isolates of SMG used in this study included three
ATCC reference strains (S. anginosus strain ATCC33397,
S. constellatus strain ATCC27823, and S. intermedius
strain ATCC27335) and 32 clinical isolates from a larger
collection described previously [13]. Isolates from invasive
infections (hip abscess, brain abscess, empyema, blood)
were obtained from the Calgary Laboratory Services,
Calgary, Canada. Airway isolates were cultured from the
sputum of CF patients during periods of stability or ex-
acerbation as part of standard patient care with ethical
approval by the Conjoint Health Ethics Board of the
Faculties of Medicine, Nursing and Kinesiology, University
of Calgary, and the Affiliated Teaching Institutions of the
Calgary Zone, Alberta Health Services. Isolates were con-
sidered associated with exacerbation when they were the
most abundant microorganism cultured and this was al-
ways at an abundance from CF sputum at numbers ≥ 1 ×
108 CFU/mL. The SMG were grown in Todd Hewitt
Broth containing 5 g/L yeast (THY) at 37°C, 5% CO2.
Twenty-four hour cultures were centrifuged at 15,000 × g
for 5 minutes, washed once with PBS and re-suspended in
PBS. CFUs were enumerated by plating serial dilutions on
THY agar followed by incubation at 37°C, 5% CO2 for
24 hours. Cell suspensions were heat-killed for 10 minutes
at 65°C. Bacterial phenotypes were characterized and pre-
viously assigned to biotypes [13,24]. Briefly, hydrolytic en-
zyme activity and hemolytic properties were determined
by plating bacteria on differential agar. Lancefield groups
were determined by a commercially available kit (Oxoid,
Nepean, Ontario, Canada).
Primary cell culture & PBMCs stimulation
Protocols were approved by the McMaster Research
Ethics Board and written informed consent was obtained
for all participants. Human PBMCs were isolated from
the heparinized venous blood of healthy human donors
(n = 3, age range 30–50 years, male:female 2:1) using
Ficoll-Paque (GE Healthcare) and Leucosep tubes (Greiner
Bio-One). Cells were cultured in X-VIVO 10 media (Lonza)
containing gentamicin and 1% autologous plasma. Cells
were seeded at a density of 5 × 105 cells/well in a 96-
well round bottom plate in a final volume of 200 μL.
Heat-killed SMG were added to freshly isolated PBMCs
in triplicate at a ratio of 5:1 (PBMCs:bacteria) in a final
volume of 210 μL. After 24 hours of stimulation, PBMCs
were centrifuged at 1,600 × g for 5 minutes and superna-
tants were collected and stored at −20°C until analyzed.
The levels of IL1β, TNF, IL10, IL23, IL12p70, IL17A, and
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IL4 were measured in cell supernatants using the MILLI-
PLEX Map Human Th17 Magnetic Bead Panel (EMD
Millipore) following the manufacturer’s recommendations
on the Luminex xMAP platform. Release of lactate de-
hydrogenase (LDH) from PBMCs was used to assess PBMC
viability using the CytoTox96 non-radioactive cytotoxicity
assay kit (Promega) following the manufacturer’s instruc-
tions. The formula (OD of treated - OD of untreated)/(OD
of complete lysis control - OD of untreated) × 100 was
used to calculate percentage of non-viable cells.
Analysis of cytokine responses
Cytokine data for each donor were scaled on a scale of 0
to 1 with highest value set to 1 to generate the heatmap
and subsequent dendrogram for the cluster analyses, as
well as for principle coordinate analysis (PCoA). Cluster
analyses were performed by calculating the distance
matrix using the Euclidean method followed by complete
linkage hierarchal clustering using the gplots package in R
version 2.15.2. PCoA was performed using the Bray-Curtis
method in the vegan package in R. For all other cytokine
analyses, data are the mean cytokine value across all three
donors and were analyzed using non-parametric statistical
tests, as indicated.
TLR2 NF-κB:SEAP reporter assay
The HEK-Blue-2 cell line (InvivoGen PlasmoTest) stably
expresses TLR2, CD14 and a secreted embryonic alkaline
phosphatase (SEAP) reporter gene inducible by the tran-
scription factors NF-κB and AP-1. These cells were cul-
tured in complete DMEM (2 mM L-glutamine, 10% fetal
bovine serum, 50 U/mL penicillin, 50 μg/mL streptomycin)
with the addition of 350 μg/mL hygromycin, 5 μg/mL blas-
ticidin, and 25 μg/mL zeocin. The cells were seeded into a
96-well flat bottom plate (BD Biosciences) at a density of
2 × 104 cells/well in complete DMEM. After 24 hours, the
medium was replaced with HEK-Blue Detection medium
(InvivoGen) and the cells were treated with 1 × 106
heat-killed SMG cells or 10-fold dilutions of Pam3CSK4
(InvivoGen) (highest final concentration of 0.1 μg/mL) as
a positive control. Each sample was studied in triplicate.
Twenty-four hours later, the absorbance was read at
630 nm using a BioTek Synergy H1 plate reader. Fold
change was calculated relative to the unstimulated control.
Results
S. anginosus, S. constellatus, and S. intermedius elicit
similar cytokine responses from human PBMCs
Thirty-five isolates of SMG were selected from our collec-
tion of characterized clinical isolates [13,25], including 12
S. anginosus, 12 S. intermedius, and 11 S. constellatus. The
isolates varied in phenotypic traits as well as in the clinical
source of isolation to represent the phenotypic and patho-
genic diversity of the SMG (Additional file 1: Table S1).
PBMCs were stimulated with heat-killed SMG for 24 hours,
after which the levels of TNF, IL1β, IL10, IL23, IL12p70,
IL17A, and IL4 were measured in cell supernatants. Since
the SMG have variable rates of growth in the tissue cul-
ture media isolates were heat-killed in order to eliminate
any variability that would occur due to bacterial growth
within the 24 hour stimulation.
The SMG induced a range of responses for each cyto-
kine tested. Overall, the SMG induced amounts of IL1β,
TNF, IL10, and IL23 10-1000-fold higher than IL12p70,
IL17A and IL4. We compared cytokine levels across spe-
cies to determine whether species classification explained
the range of responses. Within a species, isolates varied in
their ability to induce cytokine production from PBMCs,
the median of which was comparable across the three spe-
cies except for IL17A (Figure 1A-G). S. intermedius induced
significantly higher IL17A production than S. constellatus
(Figure 1F). Aside from this, the data suggest that the three
species elicit similar cytokine responses. PCoA confirmed
that the variability in cytokine production was not species
specific (Figure 2).
Cytokine profiles define a spectrum of cytokine responses
to the SMG
We next generated a heatmap of the cytokine profiles
for the 35 isolates from the three individuals and analyzed
them by hierarchal clustering to visualize isolate-specific
and donor-specific responses. The cluster analysis re-
vealed three groups of cytokine profiles: high, intermedi-
ate, and low responses (Figure 3). Isolates did not cluster
by species, corresponding with the PCoA results. Rather,
the isolates separated based on whether they originated
from invasive infections or the airway. In both the high
and intermediate response groups, 80% of isolates origi-
nated from invasive infections, compared to 20% in the
low response group of which the majority originated from
the airways. Cytokine profiles did not group invasive iso-
lates from the same source of infection (e.g. blood, brain)
together. To eliminate the possibility that the lack of cyto-
kine production for some isolates was due to cytotoxicity,
the amount of LDH released by PBMCs following stimula-
tion with the heat-killed isolates was measured. The SMG
induced a range of cell death (1-20% cytotoxicity), how-
ever, cytotoxicity did not correlate with cytokine responses
(data not shown). Thus, the spectrum of cytokine re-
sponses observed is due to differences in immunostimula-
tory properties of SMG isolates and not cell cytotoxicity.
The placement of isolates within the cytokine spectrum
and grouping of responses was consistent across the three
donors with the exception of a few isolates. The isolates
ATCC27335 and C1392 induced low cytokine production
in donors A and B, yet induced a high cytokine response
in donor C. Conversely, C260 and M60R induced low cyto-
kine responses in donor C, yet high cytokine responses in
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donors A and B. Interestingly, donor’s A and B responses
to C260 and M60R could constitute a separate response
group, as they are the only isolates to induce an IL17A re-
sponse in these donors. In addition to these differences in
donor responses to select strains, we observed an overall
divergence between donors in the production of IL23 and
IL17A. In general, donor C produced IL17A in response
to the majority of the immunostimulatory isolates but did
not produce IL23 and produced relatively low levels of
IL12p70. In contrast, donors A and B produced high levels
of IL23 but no IL17A. Although the tendency of a donor’s
response to skew towards either IL17A or IL23 held true
for the majority of the isolates, the M60R isolate induced
IL17A production in donors A and B and isolate C984 in-
duced IL23 production in donor C, indicating that these
responses are inducible. We investigated whether this
donor-specific inverse relationship between IL23 and
IL17A production also occurred in two additional donors.
Three of the five total donors tested produced IL23 and
IL12p70 but no IL17A to isolates B196, C1051, and M423
(donors A, B, and E) and the remaining two produced
IL17A but little or no IL23 and IL12p70 to the same
Figure 1 Cytokine responses to clinical isolates of the SMG. PBMCs were stimulated with 35 heat-killed isolates of the SMG (12 S. anginosus,
11 S. constellatus, and 12 S. intermedius) at a ratio of 5:1 (PBMCs:bacteria). Levels of IL1β, TNF, IL10, IL23, 12p70, IL17A and IL4 were measured in cell
supernatant after 24 hours by multiplex assaying. A-G. Box-and-whisker plots indicate median, interquartile ranges and outliers of cytokine
production in response to isolates of each species. S. ang = S. anginosus, S. const = S. constellatus, S. int = S. intermedius. Statistical significance
was determined by Kruskal-Wallis test with Dunn’s post hoc comparison. ** P < 0.01.
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isolates (donors C and D) (Figure 4A-C). These data
indicate that human variability contributes to the cyto-
kines induced in response to the SMG.
Invasive isolates induce higher IL-1β, TNF, IL-10, IL23, and
IL12p70 production than airway isolates
We next compared whether the variability in cytokine
responses was related to the source of isolation. Isolates
from acute invasive infections (blood, brain, empyema,
hip abscess) were compared to isolates from chronically
colonized CF airways. Invasive isolates induced signifi-
cantly higher production of IL1β, TNF, IL10, IL23, and
IL12p70 from PBMCs than airway isolates (Figure 5A-E),
but comparable levels of IL17A and IL4 (Figure 5F, G).
Within the invasive isolates the cytokine profiles did not
Figure 2 The SMG do not induce species-specific cytokine profiles.
PCoA analysis of scaled cytokine profiles for all 35 isolates. Isolates are
coloured by species.
Figure 3 Heatmap and cluster analysis of cytokine profiles for 35 isolates of the SMG. Heatmap colours indicate scaled cytokine data for
donors A, B, and C. Hierarchal clustering was used to generate the cluster dendrogram and cytokine response groups (high, intermediate, low)
were assigned based on the branching of the dendrogram. Isolates are labeled with the isolate ID and clinical source. + indicates isolates
originating from invasive infections. Heatmap legend: low = scaled value of 0, high = scaled value of 1.
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segregate based on infection site. These data suggest
that cytokine production, including both pro- and anti-
inflammatory cytokines, in general is an important
feature of SMG infections, however the type of infec-
tion is not associated with a specific set of cytokines.
Immunostimulatory properties of the SMG do not
correlate with their phenotypic traits
Phenotypic traits, including Lancefield grouping, β-
hemolytic activity on sheep’s blood agar, and produc-
tion of protease, DNase, HA, and CS are used clinically
to differentiate strains of the SMG [13,24,26]. Comparison
of the phenotypic traits of isolates, as previously character-
ized by Grinwis et al., [13] to cytokine production revealed
no association between phenotypic traits and induction of
TNF, IL1β, IL10, IL23 or IL4 (Table 1), except for, CS posi-
tive isolates, which induced significantly higher amounts
of IL-17A than CS negative isolates (Table 1). Grinwis
et al., also identified phenotypic “biotypes” within each
species. Biotypes are groups of isolates with shared pheno-
typic properties based on the results of 18 biochemical
tests [13]. S. anginosus isolates were grouped as phenotypic-
ally active, phenotypically non-active and HA positive, and
S. constellatus isolates were grouped as non-groupable/
Lancefield group F non-active, Lancefield group F active,
and Lancefield group C and β-hemolytic. It is suggested
that certain biotypes might be more clinically relevant
[13]; therefore we assessed whether a correlation exists be-
tween cytokine profiles and the biotypes of the isolates. S.
anginosus isolates of the active biotype and S. constellatus
isolates of the Lancefield Group F active biotype were
present in only the intermediate response group, whereas
the other biotypes were present in two or more response
groups (Table 2). Therefore, the phenotypic trait or
biotype of a clinical isolate does not enable identification
of isolates with increased immunostimulatory properties.
Immunostimulatory properties do not correlate with TLR2
activation
TLR2 is one of the primary pattern recognition recep-
tors involved in recognition of Gram-positive bacteria
and has been demonstrated to have divergent signaling
pathways that contribute to either the establishment of
commensalism or infection [27-29]. We examined whether
the SMG utilize TLR2 using a HEK293 NF-kB:SEAP re-
porter cell line expressing TLR2 and CD14. The SMG in-
duced a range of TLR2 induction (1-11-fold increase
relative to unstimulated control) (Figure 6A) comparable
to the TLR2 ligand Pam3CSK4 (Figure 6B). Comparison
of TLR2 induction by isolates based on their location in
the cytokine spectrum (low, intermediate, or high group)
revealed no significant difference and unexpectedly, some
isolates from the low cytokine response group activated
TLR2 signaling in this system as well or better than iso-
lates from the high cytokine response group (Figure 6A).
Evidently, TLR2 activation alone does not explain the
spectrum of cytokine responses to the SMG.
Discussion
The SMG are a phenotypically and genetically heteroge-
neous group of bacteria that are members of the muco-
sal microbiota yet are frequent and serious pathogens.
To date, no virulence factors have been identified that
are associated with isolates originating from invasive in-
fections, and infections do not appear to be the result of
clonal expansion of a hypervirulent strain [13,14,19]. In
this study, we investigated whether immune recognition
of the SMG distinguishes isolates of commensal or disease
origin. We demonstrated that there exists intra-species
variation in cytokine responses to the SMG, resulting in a
spectrum that ranges from high induction of both pro-
and anti-inflammatory cytokines, to little or no induction
of these cytokines. Within this spectrum, the majority of
isolates that induced the higher responses were of invasive
Figure 4 Reciprocal IL-12/IL-23 and IL17A donor responses to the SMG. PBMCs were stimulated heat-killed SMG including the S.intermedius
isolate B196 and S. anginosus isolates C1051 and M423 at a ratio of 5:1 (PBMCs:bacteria). PBMC supernatants were collected after 24 h and
IL12p70, IL23, and IL17A were measured by multiplex assaying. A. ILp1270 responses, B. IL23 responses, and C. IL17A responses for all 5 donors
are shown. Data are mean of triplicates +/− SD.
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origin. We hypothesize that these responses contribute
to whether the host recognizes the SMG as commensals
or pathogens.
No significant difference between the levels of cytokines
produced by S. anginosus, S. intermedius or S. constellatus
was observed, except for IL17A (Figure 1F). S. intermedius
induced significantly higher amounts of IL17A compared
to S. constellatus and a similar trend also exists between S.
intermedius and S. anginosus. Th17 cells are considered
the main IL17-producing cells of the adaptive immune
system, and whether this IL17 is produced from pre-
existing Th17 cell or innate immune cells such as γδ T
cells, invariant natural killer T cells, natural killer cells,
and myeloid cells is not clear (reviewed in [30]). Ongoing
studies are aimed at determining the cell type required for
IL17 production, and identifying the ligands recognized.
Aside from this difference, the similarity in cytokine re-
sponses across species suggests that immune recognition
occurs via a common surface antigen. Moreover, we did
not observe an association between phenotypic profiles
Figure 5 Induction of IL1β, TNF, IL10, IL23, IL12p70, IL17A, IL4 by invasive and airway isolates of the SMG. PBMCs were stimulated with
35 heat-killed isolates of the SMG from invasive infections (n = 19) or the airways (n =16). Levels of A. IL1β, B. TNF, C. IL10, D. IL23, E. 12p70,
F. IL17A and G. IL4 were measured in cell supernatant after 24 hours by multiplex assaying. Box-and-whisker plots indicate median, interquartile
ranges and outliers of cytokine production. Statistical significance between invasive and airway isolates was determined by a Mann–Whitney test.
*P < 0.05, **P < 0.01.
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and immunostimulatory properties (Table 1), which is
consistent with data demonstrating that pathogenicity
does not correlate with in vitro phenotypic properties such
as exoenzyme production [13,14]. The clinical source of
the isolate, whether of commensal or invasive origin,
could, however, explain the differences in cytokine pro-
duction (Figure 5). This could be due to differential ex-
pression of cell surface ligands, however, the SMG are
naturally competent [31] and analysis supports genomic
diversity [32]. Therefore, additional genetic factors that re-
sult in variation of cell-surface molecule expression could
contribute to the heterogeneity in immune recognition.
Interestingly, although levels of cytokine production as a
whole did not correlate with the phenotypic properties of
the SMG, CS positive isolates induced elevated levels of
IL17A production (Table 1). Whether this is causal or cor-
relates with other surface properties of these isolates war-
rants further investigation.
Although the mechanisms of SMG pathogenicity are
not well understood, it is well documented that the pro-
duction of pro-inflammatory cytokines, especially IL1β
and TNF are involved in both driving and preventing
pyogenic infections [33,34]. Whether the induction of
IL1β and TNF by the SMG is protective or detrimental
to the host is yet to be determined but it does appear to
be a common characteristic of invasive isolates.
We included IL23, IL12p70, and IL4 in the cytokine
panel because of their role in the polarization of CD4+
cells towards specific T helper (Th) cell lineages and
there are no data on the type of Th cell population gen-
erated in response to the SMG. The SMG induced
higher levels of IL23 than IL12p70 and IL4 (average of
12-fold induction of IL23 relative to IL12 and 66-fold in-
duction relative to IL4). IL23 contributes to development
of human Th17 cells [35,36] and enhances IL17 produc-
tion from stimulated T cells [37]. There is an increasing
amount of evidence to support a role for Th17 cells and
IL17 in the control of colonization of respiratory patho-
gens and progression to invasive infections, including
Streptococcus pneumoniae [38,39], Klebsiella pneumoniae
[40,41] and Candida albicans [42-44]. Future studies will
address whether the SMG-induced IL23 production con-
tributes to polarization of Th17 cells. Moreover, the donor
differences in IL12/23 and IL17A production (Figure 4)
could result in divergent downstream immune responses.
IL17 is a potent mediator of neutrophil chemotaxis
[45,46], and therefore differences in IL17 production
might contribute to the susceptibility to immunopa-
thology of pyogenic infections.
Since it has previously been demonstrated that resi-
dents of the airways tend to induce IL10 production that
promotes their colonization but might ultimately impair
a protective immune response during systemic infection
Table 1 Comparison of average cytokine induction by isolates based on phenotypic characteristics
Phenotype No. of
isolates
IL1β TNF IL10 IL12p70 IL23 IL17A IL4
pg/ml P value pg/ml P value pg/ml P value pg/ml P value pg/ml P value pg/ml P value pg/ml P value
Hyalurdonidase
Positive 26 5518 ns 5229 ns 916 ns 23 ns 302 ns 9 ns 6 ns
Negative 9 5089 6904 945 48 448 8 6
Chondroitan
Sulfatase
Positive 15 6099 ns 4938 ns 968 ns 23 ns 267 ns 12 0.0337 6 ns
Negative 20 4889 6201 948 33 394 6 6
β-Hemolysis
Positive 16 4892 ns 5739 ns 916 ns 32 ns 380 ns 6 ns 6 ns
Negative 19 5843 5593 996 27 306 11 6
Protease
Positive 29 5704 ns 5491 ns 889 ns 29 ns 312 ns 9 ns 6 ns
Negative 6 3976 6477 1298 29 475 4 6
P value determined by a Mann–Whitney test. P < 0.05 was considered significant.
Table 2 Proportion of S. anginosus and S. constellatus







Active 3 0 3 0
Non-Active 6 3 0 3




3 2 1 0
Lancefield Group F Active 2 0 2 0
NG/Lancefield group F
non-active
6 1 4 1
HA hyaluronidase, NG non-groupable.
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[47,48], we hypothesized that airway isolates might in-
duce IL10 and not the pro-inflammatory cytokines TNF
or IL1β. This, however, was not the case. Invasive iso-
lates produced the highest levels of IL10, and production
of IL10 appeared to be co-regulated with IL1β and TNF
(Additional file 2: Figure S1). In contrast, the airway iso-
lates induced low levels of IL10 and pro-inflammatory
cytokines in general. Since the isolates were heat-killed
and our pilot experiments demonstrated that the super-
natants did not induce a strong inflammatory response
(data not shown), we hypothesized that the differences
in cytokine responses are related to pattern-recognition
signaling in response to ligands expressed on the surface.
Since TLR2 is the dominant pattern recognition receptor
involved in recognition of surface components of Gram-
positive bacteria we used a TLR2-NF-κB reporter assay
to test this hypothesis; however, we did not observe a
correlation between TLR2 activation and cytokine pro-
duction (Figure 6A). In fact, some isolates in the low
cytokine group induced the highest TLR2 activation
(Figure 6A). Additional co-receptors or alternative pat-
tern recognition receptors on PBMCs presumably influ-
ence cytokine production.
The overall low immunostimulatory capacity of airway
isolates could be the result of a selective pressure for
minimally immunostimulatory isolates in the airways
since the inflammation that would result from a response
to more immunostimulatory isolates could compromise
lung function [49]. Therefore, immunostimulatory isolates
would be removed during this dynamic process of im-
munological homeostasis. Isolates M505 and M331, both
of which were non-immunostimulatory isolates, were cul-
tured on multiple occasions from the CF lung, supporting
the notion that non-immunostimulatory isolates are se-
lected as chronic colonizers in the airway [19]. We did,
however, observe several airway isolates in the high and
intermediate response group, including M423, M1, C984,
and M47, suggesting that there might be periodic carriage
of immunostimulatory isolates.
Despite the small the number of donors used for the
PBMC studies, we observed an isolate-dependent cytokine
response in all donors tested, supporting that such re-
sponses could determine whether an isolate is perceived
as a commensal or a pathogen in a certain individual.
Conclusions
Clinical isolates of the SMG exhibited a great degree of
intra-species variation in induction of pro- and anti-
inflammatory cytokines from human PBMCs, the mag-
nitude of which correlated with whether the isolate
originated from an invasive infection or colonization of
the airways. Consequently, isolate diversity dictates
host-responses and could ultimately result in asymptomatic
carriage or, given the right conditions (e.g. co-morbidities,
surgery or trauma, co-infection) symptomatic disease.
Additional files
Additional file 1: Table S1. Clinical source of the SMG isolates used in
this study.
Additional file 2: Figure S1. IL10 production is positively correlated
with TNF and IL1β production. Levels of IL1β, TNF, and IL10 for all 35
isolates were plotted as pairwise plots for each donor to demonstrate a
positive correlation between A-C. IL1β vs. IL10 and D-F. TNF vs. IL10. The
best-fit line and 95% confidence intervals are plotted. The r2 value was
determined by linear regression analysis.
Abbreviations
ATCC: American Typed Culture Collection; CF: Cystic fibrosis; CFU: Colony
forming unit; CS: Chondroitin sulfatase; DMEM: Dulbecco’s Modified Eagle
Medium; DNase: Deoxyribonuclease; HA: Hyaluronidase; HEK: Human
embryonic kidney; IL: Interleukin; LDH: Lactate dehydrogenase;
Figure 6 Activation of TLR2 in response to the SMG. A. HEK293 cells expressing TLR2 and an NF-κB:SEAP reporter were stimulated with
heat-killed SMG from the low (n = 15), intermediate (n = 6), or high (n = 10) cytokine response groups at a ratio of 500:1 bacteria:HEK293 cells.
Detection of SEAP expression was determined by measuring absorbance at 630 nm after 24 hours. Circles represent the relative TLR2 induction
by a single isolate. Data are the mean of three replicates. Statistical significance was determined by Kruskal-Wallis test with Dunn’s post hoc
comparison. Ns, not significant. B. Reporter cells were stimulated with serial dilutions of the TLR2 ligand Pam3CK4 for 24 hrs and OD630
was measured.
Kaiser et al. BMC Infectious Diseases 2014, 14:498 Page 9 of 11
http://www.biomedcentral.com/1471-2334/14/498
PBMC: Peripheral blood mononuclear cell; PBS: Phosphate buffered saline;
PCoA: Principle coordinate analysis; SEAP: Secreted embryonic alkaline
phosphatase; SMG: Streptococcus Milleri/Anginosus group; THY: Todd Hewitt
broth; TLR: Toll-like receptor; TNF: Tumor necrosis factor.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
JK and CV carried out experiments and performed statistical analyses. MS
and DB contributed to the conception and design of experiments. JK and
DB drafted the manuscript. All authors read and approved the final
manuscript.
Acknowledgements
This work was supported by a grant for the Canadian Institutes of Health
Research (CIHR) to MS. JK and CV were supported by a CIHR studentship and
a Canadian Thoracic Society fellowship respectively. Work in the Bowdish
laboratory is supported in part by the McMaster Immunology Research
Centre and work in the Bowdish and Surette labs is supported in part by the
M.G. DeGroote Institute for Infectious Disease Research. MS was supported as
a Canada Research Chair in Interdisciplinary Microbiome Research. We thank
members of the Bowdish and Surette laboratory for helpful discussions.
Author details
1Department of Biochemistry and Biomedical Sciences, McMaster University,
1280 Main St W, Hamilton, ON L8S 4 K1, Canada. 2Department of Pathology
& Molecular Medicine, McMaster Immunology Research Centre, McMaster
University, 1280 Main St W, Hamilton, ON L8S 4 K1, Canada. 3Department of
Medicine, Farncombe Family Digestive Health Research Institute, McMaster
University, 1280 Main St W, Hamilton, ON L8S 4 K1, Canada.
Received: 15 November 2013 Accepted: 3 September 2014
Published: 11 September 2014
References
1. Poole PM, Wilson G: Occurrence and cultural features of streptococcus
milleri in various body sites. J Clin Pathol 1979, 32(8):764–768.
2. Gossling J: Occurrence and pathogenicity of the Streptococcus milleri
group. Rev Infect Dis 1988, 10(2):257–285.
3. Deutschmann MW, Livingstone D, Cho JJ, Vanderkooi OG, Brookes JT: The
significance of Streptococcus anginosus group in intracranial
complications of pediatric rhinosinusitis. JAMA Otolaryngol Head Neck Surg
2013, 139(2):157–160.
4. Prasad KN, Mishra AM, Gupta D, Husain N, Husain M, Gupta RK: Analysis of
microbial etiology and mortality in patients with brain abscess. J Infect
2006, 53(4):221–227.
5. Pang TCY, Fung T, Samra J, Hugh TJ, Smith RC: Pyogenic liver abscess: an
audit of 10 years’ experience. World J Gastroenterol 2011, 17(12):1622–1630.
6. Alvarez Perez JA, Gonzalez JJ, Baldonedo RF, Sanz L, Carreno G, Junco A,
Rodriguez JI, Martinez MD, Jorge JI: Clinical course, treatment, and
multivariate analysis of risk factors for pyogenic liver abscess. Am J Surg
2001, 181(2):177–186.
7. Kaplan GG, Gregson DB, Laupland KB: Population-based study of the
epidemiology of and the risk factors for pyogenic liver abscess. Clin
Gastroenterol Hepatol 2004, 2(11):1032–1038.
8. Lee YQ, Kanagalingam J: Bacteriology of deep neck abscesses: a
retrospective review of 96 consecutive cases. Singapore Med J 2011,
52(5):351–355.
9. Ahmed RA, Marrie TJ, Huang JQ: Thoracic empyema in patients with
community-acquired pneumonia. Am J Med 2006, 119(10):877–883.
10. Maskell NA, Davies CW, Nunn AJ, Hedley EL, Gleeson FV, Miller R, Gabe R,
Rees GL, Peto TE, Woodhead MA, Lane DJ, Darbyshire JH, Davies RJ: U.K.
Controlled trial of intrapleural streptokinase for pleural infection. N Engl J
Med 2005, 352(9):865–874.
11. Bert F, Bariou-Lancelin M, Lambert-Zechovsky N: Clinical significance of
bacteremia involving the “Streptococcus milleri” group: 51 cases and
review. Clin Infect Dis 1998, 27(2):385–387.
12. Sibley CD, Parkins MD, Rabin HR, Duan K, Norgaard JC, Surette MG: A
polymicrobial perspective of pulmonary infections exposes an enigmatic
pathogen in cystic fibrosis patients. Proc Natl Acad Sci U S A 2008,
105(39):15070–15075.
13. Grinwis ME, Sibley CD, Parkins MD, Eshaghurshan CS, Rabin HR, Surette MG:
Characterization of Streptococcus milleri group isolates from
expectorated sputum of adult patients with cystic fibrosis. J Clin Microbiol
2010, 48(2):395–401.
14. Jacobs JA, Stobberingh EE: Hydrolytic enzymes of Streptococcus
anginosus, Streptococcus constellatus and Streptococcus intermedius in
relation to infection. Eur J Clin Microbiol Infect Dis 1995, 14(9):818–820.
15. Damjanovic D, Divangahi M, Kugathasan K, Small CL, Zganiacz A, Brown EG,
Hogaboam CM, Gauldie J, Xing Z: Negative regulation of lung inflammation
and immunopathology by TNF-alpha during acute influenza infection. Am J
Pathol 2011, 179(6):2963–2976.
16. Gwyer Findlay E, Hussell T: Macrophage-mediated inflammation and
disease: a focus on the lung. Mediators Inflamm 2012, 2012:140937.
17. Giuliano S, Rubini G, Conte A, Goldoni P, Falcone M, Vena A, Venditti M,
Morelli S: Streptococcus anginosus group disseminated infection: case
report and review of literature. Infez Med 2012, 20(3):145–154.
18. Sibley CD, Grinwis ME, Field TR, Eshaghurshan CS, Faria MM, Dowd SE,
Parkins MD, Rabin HR, Surette MG: Culture enriched molecular profiling of
the cystic fibrosis airway microbiome. PLoS One 2011, 6(7):e22702.
19. Sibley CD, Sibley KA, Leong TA, Grinwis ME, Parkins MD, Rabin HR, Surette
MG: The Streptococcus milleri population of a cystic fibrosis clinic
reveals patient specificity and intraspecies diversity. J Clin Microbiol 2010,
48(7):2592–2594.
20. Larsen JM, Steen-Jensen DB, Laursen JM, Sondergaard JN, Musavian HS, Butt TM,
Brix S: Divergent pro-inflammatory profile of human dendritic cells in
response to commensal and pathogenic bacteria associated with the
airway microbiota. PLoS One 2012, 7(2):e31976.
21. Frodermann V, Chau TA, Sayedyahossein S, Toth JM, Heinrichs DE, Madrenas JN:
A modulatory interleukin-10 response to staphylococcal peptidoglycan
prevents Th1/Th17 adaptive immunity to staphylococcus aureus. J Infect Dis
2011, 204(2):253–262.
22. Peres AG, Madrenas J: The broad landscape of immune interactions with
Staphylococcus aureus: from commensalism to lethal infections. Burns
2013, 39(3):380–388.
23. Chau TA, McCully ML, Brintnell W, An G, Kasper KJ, Vines ED, Kubes P,
Haeryfar SM, McCormick JK, Cairns E, Heinrichs DE, Madrenas J: Toll-like
receptor 2 ligands on the staphylococcal cell wall downregulate
superantigen-induced T cell activation and prevent toxic shock
syndrome. Nat Med 2009, 15(6):641–648.
24. Clarridge JE 3rd, Osting C, Jalali M, Osborne J, Waddington M: Genotypic
and phenotypic characterization of “Streptococcus milleri” group isolates
from a veterans administration hospital population. J Clin Microbiol 1999,
37(11):3681–3687.
25. Grinwis ME, Sibley CD, Parkins MD, Eshaghurshan CS, Rabin HR, Surette MG:
Macrolide and clindamycin resistance in Streptococcus milleri group
isolates from the airways of cystic fibrosis patients. Antimicrob Agents
Chemother 2010, 54(7):2823–2829.
26. Whiley RA, Fraser H, Hardie JM, Beighton D: Phenotypic differentiation of
Streptococcus intermedius, Streptococcus constellatus, and
Streptococcus anginosus strains within the “Streptococcus milleri
group”. J Clin Microbiol 1990, 28(7):1497–1501.
27. Round JL, Lee SM, Li J, Tran G, Jabri B, Chatila TA, Mazmanian SK: The
Toll-like receptor 2 pathway establishes colonization by a commensal of
the human microbiota. Science 2011, 332(6032):974–977.
28. Jeon SG, Kayama H, Ueda Y, Takahashi T, Asahara T, Tsuji H, Tsuji NM,
Kiyono H, Ma JS, Kusu T, Okumura R, Hara H, Yoshida H, Yamamoto M,
Nomoto K, Takeda K: Probiotic bifidobacterium breve induces
IL-10-producing Tr1 cells in the colon. PLoS Pathog 2012,
8(5):e1002714.
29. Smits HH, Engering A, van der Kleij D, de Jong EC, Schipper K, van Capel TM,
Zaat BA, Yazdanbakhsh M, Wierenga EA, van Kooyk Y, Kapsenberg ML:
Selective probiotic bacteria induce IL-10-producing regulatory T cells
in vitro by modulating dendritic cell function through dendritic cell-specific
intercellular adhesion molecule 3-grabbing nonintegrin. J Allergy Clin
Immunol 2005, 115(6):1260–1267.
30. Cua DJ, Tato CM: Innate IL-17-producing cells: the sentinels of the immune
system. Nat Rev Immunol 2010, 10(7):479–489.
31. Havarstein LS, Hakenbeck R, Gaustad P: Natural competence in the genus
Streptococcus: evidence that streptococci can change pherotype by
Kaiser et al. BMC Infectious Diseases 2014, 14:498 Page 10 of 11
http://www.biomedcentral.com/1471-2334/14/498
interspecies recombinational exchanges. J Bacteriol 1997,
179(21):6589–6594.
32. Olson AB, Kent H, Sibley CD, Grinwis ME, Mabon P, Ouellette C, Tyson S,
Graham M, Tyler SD, Van Domselaar G, Surette MG, Corbett CR:
Phylogenetic relationship and virulence inference of Streptococcus
Anginosus Group: curated annotation and whole-genome comparative
analysis support distinct species designation. BMC Genomics 2013, 14:895.
33. Cho JS, Guo Y, Ramos RI, Hebroni F, Plaisier SB, Xuan C, Granick JL,
Matsushima H, Takashima A, Iwakura Y, Cheung AL, Cheng G, Lee DJ, Simon SI,
Miller LS: Neutrophil-derived IL-1beta is sufficient for abscess formation
in immunity against Staphylococcus aureus in mice. PLoS Pathog 2012,
8(11):e1003047.
34. Vossen MG, Gattringer KB, Khalifeh N, Koreny M, Spertini V, Mallouhi A,
Willeit M, Volc-Platzer B, Asboth F, Graninger W, Thalhammer F, Lagler H:
Gemella morbillorum bacteremia after anti-tumor necrosis factor alpha
as acne inversa therapy. J Clin Microbiol 2012, 50(3):1109–1112.
35. Wilson NJ, Boniface K, Chan JR, McKenzie BS, Blumenschein WM, Mattson JD,
Basham B, Smith K, Chen T, Morel F, Lecron JC, Kastelein RA, Cua DJ,
McClanahan TK, Bowman EP, de Waal Malefyt R: Development, cytokine
profile and function of human interleukin 17-producing helper T cells.
Nat Immunol 2007, 8(9):950–957.
36. Manel N, Unutmaz D, Littman DR: The differentiation of human T(H)-17
cells requires transforming growth factor-beta and induction of the
nuclear receptor RORgammat. Nat Immunol 2008, 9(6):641–649.
37. Hoeve MA, Savage ND, de Boer T, Langenberg DM, de Waal MR, Ottenhoff TH,
Verreck FA: Divergent effects of IL-12 and IL-23 on the production of IL-17
by human T cells. Eur J Immunol 2006, 36(3):661–670.
38. Zhang Z, Clarke TB, Weiser JN: Cellular effectors mediating Th17-dependent
clearance of pneumococcal colonization in mice. J Clin Invest 2009,
119(7):1899–1909.
39. Lu YJ, Gross J, Bogaert D, Finn A, Bagrade L, Zhang Q, Kolls JK, Srivastava A,
Lundgren A, Forte S, Thompson CM, Harney KF, Anderson PW, Lipsitch M,
Malley R: Interleukin-17A mediates acquired immunity to pneumococcal
colonization. PLoS Pathog 2008, 4(9):e1000159.
40. Aujla SJ, Chan YR, Zheng M, Fei M, Askew DJ, Pociask DA, Reinhart TA,
McAllister F, Edeal J, Gaus K, Husain S, Kreindler JL, Dubin PJ, Pilewski JM,
Myerburg MM, Mason CA, Iwakura Y, Kolls JK: IL-22 mediates mucosal host
defense against gram-negative bacterial pneumonia. Nat Med 2008,
14(3):275–281.
41. Ye P, Rodriguez FH, Kanaly S, Stocking KL, Schurr J, Schwarzenberger P,
Oliver P, Huang W, Zhang P, Zhang J, Shellito JE, Bagby GJ, Nelson S,
Charrier K, Peschon JJ, Kolls JK: Requirement of interleukin 17 receptor
signaling for lung CXC chemokine and granulocyte colony-stimulating
factor expression, neutrophil recruitment, and host defense. J Exper Med
2001, 194(4):519–527.
42. Conti HR, Shen F, Nayyar N, Stocum E, Sun JN, Lindemann MJ, Ho AW,
Hai JH, Yu JJ, Jung JW, Filler SG, Masso-Welch P, Edgerton M, Gaffen SL:
Th17 cells and IL-17 receptor signaling are essential for mucosal host
defense against oral candidiasis. J Exp Med 2009, 206(2):299–311.
43. Pandiyan P, Conti HR, Zheng L, Peterson AC, Mathern DR, Hernandez-Santos N,
Edgerton M, Gaffen SL, Lenardo MJ: CD4(+)CD25(+)Foxp3(+) regulatory T
cells promote Th17 cells in vitro and enhance host resistance in mouse
Candida albicans Th17 cell infection model. Immunity 2011, 34(3):422–434.
44. Hernandez-Santos N, Huppler AR, Peterson AC, Khader SA, McKenna KC,
Gaffen SL: Th17 cells confer long-term adaptive immunity to oral mucosal
Candida albicans infections. Mucosal Immunol 2013, 6(5):900–910.
45. Miyamoto M, Prause O, Sjostrand M, Laan M, Lotvall J, Linden A:
Endogenous IL-17 as a mediator of neutrophil recruitment caused by
endotoxin exposure in mouse airways. J Immunol 2003, 170(9):4665–4672.
46. Laan M, Cui ZH, Hoshino H, Lotvall J, Sjostrand M, Gruenert DC, Skoogh BE,
Linden A: Neutrophil recruitment by human IL-17 via C-X-C chemokine
release in the airways. J Immunol 1999, 162(4):2347–2352.
47. Rose WE, Eickhoff JC, Shukla SK, Pantrangi M, Rooijakkers S, Cosgrove SE,
Nizet V, Sakoulas G: Elevated serum interleukin-10 at time of hospital
admission is predictive of mortality in patients with Staphylococcus
aureus bacteremia. J Infect Dis 2012, 206(10):1604–1611.
48. Wertheim HF, Vos MC, Ott A, van Belkum A, Voss A, Kluytmans JA, van
Keulen PH, Vandenbroucke-Grauls CM, Meester MH, Verbrugh HA: Risk and
outcome of nosocomial Staphylococcus aureus bacteraemia in nasal
carriers versus non-carriers. Lancet 2004, 364(9435):703–705.
49. Holt PG, Strickland DH, Wikstrom ME, Jahnsen FL: Regulation of
immunological homeostasis in the respiratory tract. Nat Rev Immunol
2008, 8(2):142–152.
doi:10.1186/1471-2334-14-498
Cite this article as: Kaiser et al.: Host cytokine responses distinguish
invasive from airway isolates of the Streptococcus milleri/anginosis
group. BMC Infectious Diseases 2014 14:498.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Kaiser et al. BMC Infectious Diseases 2014, 14:498 Page 11 of 11
http://www.biomedcentral.com/1471-2334/14/498
